Sfoglia per AUTORE
MENDOLARO M
Collezione AO Ordine Mauriziano
Items : 5
Editorial: Endoscopic Activity is an Essential Tool for Patients' Management, Even in Mild Crohn's Disease. in Alimentary pharmacology & therapeutics / Aliment Pharmacol Ther. 2025 Apr;61(7):1240-1241. doi: 10.1111/apt.70015. Epub 2025 Feb 15.
2025
AO Ordine Mauriziano
AO Ordine Mauriziano
Mendolaro M; Daperno M;
A case of refractory severe pyoderma gangrenosum successfully treated with upadacitinib. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2024 Jul;56(7):1248. doi: 10.1016/j.dld.2024.03.016. Epub 2024 Apr 20.
2024
AO Ordine Mauriziano
AO Ordine Mauriziano
Mendolaro M; Morello E; Salacone P; Rocca R;
Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform. in Scandinavian journal of gastroenterology / Scand J Gastroenterol. 2023 Mar;58(3):240-247. doi: 10.1080/00365521.2022.2124538. Epub 2022 Sep 23.
2023
ASL Torino 4
AO Ordine Mauriziano
ASL Torino 4
AO Ordine Mauriziano
Rocca R; Cosimato M; Morello E; Mendolaro M; Lavagna A; Carli E; Colombo A; Figini V; Giuffrida E; Mangia M; Pagana G; Daperno M; Mangia M; Giuffrida E; Figini V; Colombo A; Carli E; Lavagna A; Mendolaro M; Morello E; Cosimato M; Rocca R; Pagana G; Daperno M;
Predictivity of early and late assessment for post-surgical recurrence of Crohn's disease: Data from a single-center retrospective series. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2021 Aug;53(8):987-995. doi: 10.1016/j.dld.2020.09.018. Epub 2020 Oct 22.
2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Daperno M; Ferrero A; Rocca R; Ercole E; Lavagna A; Morello E; Rigazio C; Guiotto C; Massucco P; Cosimato M; Randazzo C; Mineccia M; Dal Piaz G; Mendolaro M;
Switching from infliximab originator to a first biosimilar is safe and effective. Results of a case-control study with drug levels and antibodies evaluation. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2019 Aug;51(8):1117-1122. doi: 10.1016/j.dld.2019.05.018. Epub 2019 Jul 2.
2019
AO Ordine Mauriziano
AO Ordine Mauriziano
Guiotto C; Italia A; Lavagna A; Rigazio C; Cosimato M; Ercole E; Mendolaro M; Rocca R; Daperno M;